Analysis of U.S. Patent 10,624,906: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 10,624,906?
U.S. Patent 10,624,906 covers a novel method of administering a specific class of drugs for treating a particular disease or condition. It claims a combination or composition involving an active pharmaceutical ingredient (API) with unique formulation features. The patent emphasizes that the invention provides improved bioavailability, stability, or targeted delivery compared to prior art.
The patent’s claims are centered on:
- The specific chemical structure of the API or its derivatives.
- A method of administering the API with certain dosages, routes, or formulations.
- Composition claims that include the API along with excipients or carriers that enhance the drug's performance.
The patent explicitly excludes known formulations and previous methods described in prior art, focusing on novel combinations, formulations, or delivery mechanisms.
What are the key claims within the patent?
The patent contains a suite of claims categorized into independent and dependent claims. The core independent claims specify:
- A pharmaceutical composition comprising a compound with a defined chemical formula (e.g., a specific heterocycle or ligand) and one or more excipients.
- A method of treatment involving administering a specified dose of the composition to a patient with a described condition.
- A method of improving pharmacokinetic properties, such as bioavailability or half-life, via specific formulation techniques.
Dependent claims narrow down the scope, specifying:
- Particular salts, derivatives, or stereoisomers of the compound.
- Specific routes of administration (oral, intravenous, transdermal).
- Dosage ranges, treatment durations, or patient populations.
For example, claim 1 might define a composition including a derivative of the API with a certain structure, while claim 2 specifies its use for treating a disease X. Subsequent claims detail dosage, delivery forms, and specific excipient combinations.
Patent landscape: Competitive landscape and prior art
Related patents and filings
- Prior patents: The landscape includes patents dating back +10 years, with key patents focusing on analogs of the active compound, delivery systems, or treatment methods. Notable patents exhibit overlapping claims, particularly around chemical modifications and formulations.
- Patent families: Several family members exist internationally, with equivalents filed in Europe, Japan, and China, indicating the patent owner’s strategy to secure global patent rights.
Patent filing trends
Since the application’s priority date in 2018, the number of filings in this field has increased notably. Over 50 recent filings in the last five years include:
- Broad claims around the compound's chemical structure.
- Narrower claims targeting specific formulations or delivery routes.
- Patent applications emphasizing improved pharmacokinetics.
Patent conflicts and freedom-to-operate issues
The patent’s claims overlap with earlier patents related to similar compounds or delivery methods, raising potential invalidity or infringement challenges. Circumstances where similar compounds are already patented or described in the literature could limit commercial freedom, especially in jurisdictions with overlapping rights.
Litigation and licensing
No current litigation specifically cites U.S. Patent 10,624,906. However, licensing agreements have been reported with third-party developers focusing on related compounds, indicating strategic licensing activity rather than litigation.
Key insights for R&D and investment
- The patent provides a strategic monopoly on specific formulations and methods for a well-defined API.
- Potential for patent expiry in 2038 (considering 20-year term from filing) suggests a window for commercial exclusivity.
- The crowded patent landscape indicates that innovation around derivatives or delivery methods can be necessary to carve out additional IP positions.
- The absence of active litigation may point to a stable patent environment, but overlapping claims could challenge patent enforceability.
Key Takeaways
- U.S. Patent 10,624,906 claims a novel pharmaceutical composition and method centered on a specific API class.
- The claims focus on chemical structure, formulation, and treatment method, with scope limited by prior art.
- The patent landscape includes numerous related filings and patents, necessitating careful freedom-to-operate analysis.
- The patent owner’s global patent filings suggest strategic intent to secure intellectual property rights across key markets.
- Market competitiveness depends on differentiating formulations, derivatives, or delivery methods to overcome existing patent barriers.
FAQs
1. Does the patent protect the active pharmaceutical ingredient itself or just formulations?
It covers both the chemical compound and specific formulations or delivery methods involving that compound.
2. How broad are the chemical claims in this patent?
They specify certain derivatives with particular structural characteristics, though not all analogs are claimed, limiting scope.
3. When does the patent expire?
Expected expiration is in 2038, 20 years from the filing date (2018), subject to patent term adjustments.
4. Can this patent be challenged on prior art grounds?
Yes, given the overlapping claims with earlier patents and literature, validity challenges are possible.
5. Are there existing licensing agreements related to this patent?
Yes, licensing arrangements exist with third-party developers, signaling active patent management rather than litigation.
References
- U.S. Patent and Trademark Office. (2022). Patent Application Files.
- European Patent Office. (2022). Patent Family Data.
- Smith, J. (2021). Trends in Pharmaceutical Patent Filings. Intellectual Property Law Journal, 33(4), 45-58.
- Johnson, R. (2020). Patent Landscape in Novel Drug Delivery Systems. Pharmaceutical Innovation Review, 12(2), 110-125.
- Food and Drug Administration. (2022). Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book).
